Epidemiological characteristics of malignant neoplasms of reproductive system organs in people aged 15 to 39 years in the Russian Federation

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To analyze morbidity and mortality from malignant neoplasms (MNs) of the reproductive system organs in men and women aged 15 to 39 years in the Russian Federation due to the fact that improving demographic indicators is a priority in the development of medical science in Russia.

Subjects and methods. The authors analyzed official cancer statistic data in Russia over 2008–2020. The analysis included individual MNs of the reproductive organs in people aged 15 to 39 years. Morbidity and mortality rates from MNs of the reproductive organs were calculated in this age group; the corresponding confidence intervals are presented.

Results. The investigation revealed an increase in morbidity and no decline in mortality from MNs of the reproductive system organs among young men and women from 2008 to 2019; since 2020 there has been a decrease in morbidity and mortality, which may be associated with the COVID-19 pandemic. The highest indicators were found in the group of 30–39 years. The incidence rates were in aggregate higher in the women than in the men of all age groups.

Conclusion. The study emphasizes the necessity of developing and optimizing measures to prevent reproductively significant cancers in the adolescent and adult populations.

Full Text

Restricted Access

About the authors

Viktoria S. Yudina

I.M. Sеchenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Email: viktoriayudina@bk.ru
Scopus Author ID: 0000-0002-4925-5421

Postgraduate Student

Russian Federation, Moscow

Platon D. Lopukhov

I.M. Sеchenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Email: pl2211@yandex.ru
ORCID iD: 0000-0002-0872-2214

Cand. Med. Sci., Associate Professor, Department of Epidemiology and Evidence-Based Medicine

Russian Federation, Moscow

Olga I. Trushina

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

Email: o.trushina@list.ru
ORCID iD: 0000-0002-9101-180X

MD, Senior Researcher

Russian Federation, Moscow

Svetlana V. Mukhtarulina

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

Email: svmukhtarulina@yandex.ru

MD, Head, Department of Gynecology with Chemotherapy

Russian Federation, Moscow

Andrey D. Kaprin

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

Email: contact@nmicr.ru
ORCID iD: 0000-0001-8784-8415

Academician of the Russian Academy of Sciences, MD, Honored Doctor of the Russian Federation; Academician of the Russian Academy of Education, MD, Professor, Director General

Russian Federation, Moscow

Oleg I. Apolikhin

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center

Email: call@niiuro.ru
ORCID iD: 0000-0003-0206-043X

Corresponding Member of the Russian Academy of Sciences, MD, Director

Russian Federation, Moscow

Nikolai I. Briko

I.M. Sеchenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Author for correspondence.
Email: briko_n_i@staff.sechenov.ru
Scopus Author ID: 0000-0002-6446-2744

Academician of the Russian Academy of Sciences, MD, Director

Russian Federation, Moscow

References

  1. Hepner A., Negrini D., Hase E.A., Exman P., Testa L., Trinconi A.F. et al. Cancer During Pregnancy: The Oncologist Overview. World J. Oncol. 2019; 10(1): 28–34. doi: 10.14740/wjon1177
  2. Lambertini M., Del Mastro L., Pescio M.C., Andersen C.Y., Azim H.A.Jr., Peccatori F.A. et al. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med. 2016; 14:1. doi: 10.1186/s12916-015-0545-7
  3. Ljungman L., Eriksson L.E., Flynn K.E., Gorman J.R., Ståhl O., Weinfurt K. et al. Sexual Dysfunction and Reproductive Concerns in Young Men Diagnosed With Testicular Cancer: An Observational Study. J. Sex. Med. 2019;16(7): 1049–59. doi: 10.1016/j.jsxm.2019.05.005
  4. Петров Ю.А., Купина А.Д., Шаталов А.Е. Вероятность беременности и родов после онкологических заболеваний (обзор). Кубанский научный медицинский вестник. 2020; 27(5): 163–74. doi: 10.25207/1608-6228-2020-27-5-163-174. Petrov Yu.A., Kupina A.D., Shatalov A.E. [Probability of pregnancy and childbirth after oncological diseases (review)]. Kuban Scientific Medical Bulletin.. 2020; 27(5): 163–74. (In Russ.). doi: 10.25207/1608-6228-2020-27-5-163-174.
  5. Scott A.R., Stoltzfus K.C., Tchelebi L.T., Trifiletti D.M., Lehrer E.J., Rao P. et al. Trends in Cancer Incidence in US Adolescents and Young Adults, 1973–2015. JAMA Netw Open. 2020; 3(12): e2027738 doi: 10.1001/jamanetworkopen.2020.27738
  6. Miller K.D., Fidler-Benaoudia M., Keegan T.H., Hipp H.S., Jemal A., Siegel R.L. Cancer statistics for adolescents and young adults, 2020. CA Cancer J. Clin. 2020;70(6): 443–59. doi: 10.3322/caac.21637.
  7. Close A.G., Dreyzin A., Miller K.D., Seyneve B.K.N., Rapkin L.B. Adolescent and young adult oncology-past, present, and future. CA Cancer. J. Clin. 2019; 69(6): 485–96. doi: 10.3322/caac.21585
  8. Ferrari A., Stark D., Peccatori F.A., Fern L., Laurence V., Gaspar N. et al. Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE). ESMO Open. 2021; 6(2): 100096. doi: 10.1016/j.esmoop.2021.100096
  9. Каприн А.Д., Старинский В.В., Шахзадова А.О. (ред.). Злокачественные новообразования в России в 2020 году (Заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2021. Kaprin A., Starinsky V., Shakhzadova A. (eds.). [Malignant neoplasms in Russia in 2020 (morbidity and mortality)]. Moscow, 2021. (In Russ.).
  10. de Martel C., Georges D., Bray F., Ferlay J., Clifford G.M. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob. Health. 2020; 8(2): e180–90. doi: 10.1016/S2214-109X(19)30488-7
  11. Стилиди И.С., Заридзе Д.Г., Максимович Д.М., Дзитиев Д.М. Снижение заболеваемости злокачественными опухолями – еще одно последствие эпидемии СОVID-19. Общественное здоровье 2022; 2(1): 5–14. doi: 10.21045/2782-1676-2021-2-1-5-14. Stilidi I., Zaridze D., Maksimovich D., Dzitiev D. [Reducing the incidence of malignant tumors is another consequence of the COVID-19 epidemic]. Public Health. 2022; 2(1): 5–14. (In Russ.). doi: 10.21045/2782-1676-2021-2-1-5-14
  12. Dinmohamed A.G., Visser O., Verhoeven R. H.A., van Nederveen FH, Willems SM, Merkx MAW, et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020; 21(6): 750–1. doi: 10.1016/S1470-2045(20)30265-5
  13. Dinmohamed A.G., Cellamare M., Visser O. et al. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands. J. Hematol. Oncol. 2020; 13(147): 1–4. DOI: 10.1186/ s13045-020-00984-1
  14. You L., Lv Z., Li C., Ye W., Zhou Y., Jin J. Worldwide cancer statistics of adolescents and young adults in 2019: a systematic analysis of the Global Burden of Disease Study 2019. ESMO Open. 2021; 6(5): 100255. doi: 10.1016/j.esmoop.2021.100255
  15. Momenimovahed Z., Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer (Dove Med Press) 2019; (11): 151–64. doi: 10.2147/BCTT.S176070
  16. Trama A., Botta L., Steliarova-Foucher E. Cancer Burden in Adolescents and Young Adults: A Review of Epidemiological Evidence. Cancer J. 2018; 24(6): 256–66. doi: 10.1097/PPO.0000000000000346
  17. Зароченцева Н.В., Белая Ю.М. Гинекологическая заболеваемость девочек в Московской области в период проведения программы вакцинопрофилактики папилломавирусной инфекции. Гинекология 2021; 20(8): 23–7. doi: 10.31550/1727-2378-2021-20-8-23-27. Zarochentseva N., Belaya Yu. [Gynecological morbidity of girls in the Moscow region during the program of vaccination against human papillomavirus infection]. Gynecology 2021; 20(8): 23–7. (In Russ.).doi: 10.31550/1727-2378-2021-20-8-23-27.
  18. Roy R.K., Casson K. Attitudes Toward Testicular Cancer and Self-Examination Among Northern Irish Males. Am. J. Mens. Health. 2017; 11(2): 253–61. doi: 10.1177/1557988316668131
  19. Saab M.M., Davoren M., Murphy A., Murphy D., Cooke E. et al. Promoting men’s awareness, self-examination, and help-seeking for testicular disorders: a systematic review of interventions. HRB Open Res. 2018; (1): 16. doi: 10.12688/hrbopenres.12837.2.
  20. Wen Y.F, Chen M.X., Yin G., Lin R., Zhong Y.J., Dong Q.Q. et al. The global, regional, and national burden of cancer among adolescents and young adults in 204 countries and territories, 1990–2019: a population-based study. J. Hematol. Oncol. 2021; 14(1): 89. doi: 10.1186/s13045-021-01093-3

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. Morbidity (a) and mortality (b) from MNs of the reproductive system organs in persons aged 15-39 years in the Russian Federation over 2008-2020

Download (366KB)
Indexing metadata
3. Fig. 2. The incidence of the modt common MNs of the reproductive organs in the age groups of 15-39 years in the Russian Federation over 2008-2020

Download (354KB)
Indexing metadata
4. Fig. 3. Time course of changes in the average age at which MN was diagnosed for the first time in life and the Russian Federation in 1998-2020 a – cervical cancer; b – cancer of the corpus uteri; c – breast cancer; d – ovarian cancer.

Download (503KB)
Indexing metadata

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies